Advertisement

Ursolic acid from the Chinese herb Danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells

      Abstract

      Danshen, the dried root of Salvia miltiorrhiza Bunge (Lamiaceae), is one of the most commonly used traditional Chinese medicines for cardiovascular indications. In EA.hy 926 cells, a cell line derived from human umbilical vein endothelial cells (HUVEC), an aqueous extract of Danshen, and also a methanol extract of the plant, increased eNOS promoter activity, eNOS mRNA and protein expression, as well as endothelial NO production. A dichloromethane extract, in contrast, did not change eNOS gene expression. Thus, the active Danshen constituent(s) responsible for eNOS upregulation is (are) hydrophilic and/or alcohol-soluble. One such compound is ursolic acid that significantly increased eNOS expression in EA.hy 926 cells and native HUVEC, and enhanced bioactive NO production measured in terms of its cGMP increasing activity. Other tested hydrophilic and alcohol-soluble compounds isolated from Danshen had no effect on eNOS expression. Interestingly, ursolic acid also reduced the expression of the NADPH oxidase subunit Nox4 and suppressed the production of reactive oxygen species in human endothelial cells. Upregulation of eNOS and a parallel downregulation of Nox4 lead to an increase in bioactive NO. This in turn could mediate some of the beneficial effects of Danshen. Ursolic acid is a prototypical compound responsible for this effect of the plant.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zhou L.
        • Zuo Z.
        • Chow M.S.
        Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.
        J Clin Pharmacol. 2005; 45: 1345-1359
        • Lei X.L.
        • Chiou G.C.
        Studies on cardiovascular actions of Salvia miltiorrhiza.
        Am J Chin Med. 1986; 14: 26-32
        • Lam F.F.
        • Yeung J.H.
        • Cheung J.H.
        Mechanisms of the dilator action of Danshen (Salvia miltiorrhiza) on rat isolated femoral artery.
        J Cardiovasc Pharmacol. 2005; 46: 361-368
        • Ji X.
        • Tan B.K.
        • Zhu Y.C.
        • et al.
        Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats.
        Life Sci. 2003; 73: 1413-1426
        • Wu T.W.
        • Zeng L.H.
        • Fung K.P.
        • et al.
        Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells.
        Biochem Pharmacol. 1993; 46: 2327-2332
        • Wang Z.
        • Roberts J.M.
        • Grant P.G.
        • et al.
        The effect of a medicinal Chinese herb on platelet function.
        Thromb Haemost. 1982; 48: 301-306
        • Chen Y.H.
        • Lin S.J.
        • Ku H.H.
        • et al.
        Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells.
        J Cell Biochem. 2001; 82: 512-521
        • Chen Y.L.
        • Yang S.P.
        • Shiao M.S.
        • et al.
        Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits.
        J Cell Biochem. 2001; 83: 484-493
        • Wu Y.J.
        • Hong C.Y.
        • Lin S.J.
        • et al.
        Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
        Arterioscler Thromb Vasc Biol. 1998; 18: 481-486
        • Li H.
        • Oehrlein S.A.
        • Wallerath T.
        • et al.
        Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene.
        Mol Pharmacol. 1998; 53: 630-637
        • Li H.
        • Xia N.
        • Brausch I.
        • et al.
        Flavonoids from artichoke (Cynara scolymus L.) up-regulate endothelial-type nitric-oxide synthase gene expression in human endothelial cells.
        J Pharmacol Exp Ther. 2004; 310: 926-932
        • Li H.
        • Junk P.
        • Huwiler A.
        • et al.
        Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase.
        Circulation. 2002; 106: 2250-2256
        • Li H.
        • Forstermann U.
        Structure-activity relationship of staurosporine analogs in regulating expression of endothelial nitric-oxide synthase gene.
        Mol Pharmacol. 2000; 57: 427-435
        • Daiber A.
        • August M.
        • Baldus S.
        • et al.
        Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012.
        Free Radic Biol Med. 2004; 36: 101-111
        • Li H.
        • Forstermann U.
        Nitric oxide in the pathogenesis of vascular disease.
        J Pathol. 2000; 190: 244-254
        • Kuhlencordt P.J.
        • Gyurko R.
        • Han F.
        • et al.
        Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.
        Circulation. 2001; 104: 448-454
        • Li H.
        • Wallerath T.
        • Munzel T.
        • et al.
        Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs.
        Nitric Oxide. 2002; 7: 149-164
        • O K Cheung F.
        • Sung F.L.
        • et al.
        Effect of magnesium tanshinoate B on the production of nitric oxide in endothelial cells.
        Mol Cell Biochem. 2000; 207: 35-39
        • Luo W.B.
        • Wang Y.P.
        Magnesium lithospermate B inhibits hypoxia-induced calcium influx and nitric oxide release in endothelial cells.
        Acta Pharmacol Sin. 2001; 22: 1135-1142
        • Chen Y.
        • Ruan Y.
        • Li L.
        • et al.
        Effects of Salvia miltiorrhiza extracts on rat hypoxic pulmonary hypertension, heme oxygenase-1 and nitric oxide synthase.
        Chin Med J (Engl). 2003; 116: 757-760
        • Zhou Z.
        • Wang S.Q.
        • Liu Y.
        • et al.
        Cryptotanshinone inhibits endothelin-1 expression and stimulates nitric oxide production in human vascular endothelial cells.
        Biochim Biophys Acta. 2006; 1760: 1-9
        • Wang X.
        • Morris-Natschke S.L.
        • Lee K.H.
        New developments in the chemistry and biology of the bioactive constituents of Tanshen.
        Med Res Rev. 2007; 27: 133-148
        • Kong D.Y.
        Chemical constituents of Salvia miltiorrhiza.
        Zhongguo Yiyao Gongye Zazhi. 1989; 20: 279-285
        • Baricevic D.
        • Sosa S.
        • Della Loggia R.
        • et al.
        Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid.
        J Ethnopharmacol. 2001; 75: 125-132
        • Aguirre-Crespo F.
        • Vergara-Galicia J.
        • Villalobos-Molina R.
        • et al.
        Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta.
        Life Sci. 2006; 79: 1062-1068
        • Kowalski R.
        Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types.
        J Agric Food Chem. 2007; 55: 656-662
        • Hink U.
        • Li H.
        • Mollnau H.
        • et al.
        Mechanisms underlying endothelial dysfunction in diabetes mellitus.
        Circ Res. 2001; 88: E14-E22
        • Mollnau H.
        • Wendt M.
        • Szocs K.
        • et al.
        Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
        Circ Res. 2002; 90: e58-e65
        • Forstermann U.
        • Munzel T.
        Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
        Circulation. 2006; 113: 1708-1714
        • Li H.
        • Witte K.
        • August M.
        • et al.
        Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats.
        J Am Coll Cardiol. 2006; 47: 2536-2544
        • Li H.
        • Hergert S.M.
        • Schafer S.C.
        • et al.
        Midostaurin upregulates eNOS gene expression and preserves eNOS function in the microcirculation of the mouse.
        Nitric Oxide. 2005; 12: 231-236
        • Wallerath T.
        • Deckert G.
        • Ternes T.
        • et al.
        Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.
        Circulation. 2002; 106: 1652-1658
        • Wallerath T.
        • Poleo D.
        • Li H.
        • et al.
        Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects.
        J Am Coll Cardiol. 2003; 41: 471-478
        • Ago T.
        • Kitazono T.
        • Ooboshi H.
        • et al.
        Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase.
        Circulation. 2004; 109: 227-233